Biodegradable Stents Market

The biodegradable stents market is rapidly evolving within the broader medical devices industry. Biodegradable stents, also known as bioresorbable or bioabsorbable stents, are used in the treatment of coronary artery diseases or peripheral artery diseases. These stents are designed to open up blocked arteries and gradually dissolve in the body over a period of time, eliminating the need for a permanent metallic implant and reducing the risk of complications associated with traditional stents. The global biodegradable stents market is driven by several factors including the rising prevalence of cardiovascular diseases, advancements in technology, and the growing preference for minimally invasive procedures. The market is also influenced by the increasing demand for better and safer alternatives to traditional stents, which can cause long-term complications such as thrombosis and restenosis. Furthermore, growing awareness about the benefits of biodegradable stents, such as their ability to restore the natural movement and function of the artery, is also contributing to the growth of the market. However, the high cost of these stents and the stringent regulatory approval process may hinder the market growth to some extent. Despite these challenges, the biodegradable stents market holds immense potential for growth, with numerous opportunities for existing players and new entrants. The market is characterized by intense competition, with key players focusing on research and development activities to introduce innovative products and gain a competitive edge. The future of the biodegradable stents market looks promising, with increasing adoption in the healthcare sector and growing recognition of their benefits over traditional stents.

Market Dynamics:

The global biodegradable stents market is primarily driven by the growing preference for minimally invasive procedures, rising geriatric population worldwide prone to cardiac ailments, and increasing incidence of coronary and peripheral artery diseases. Additionally, favorable reimbursement policies and regulatory approvals are promoting the adoption of biodegradable stents. However, the high cost of biodegradable stents compared to conventional metallic stents and lack of long-term performance data are the major factors negatively impacting the market growth.  

 Key Features of the Study:

• This report provides an in-depth analysis of the global biodegradable stents market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global biodegradable stents market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Boston Scientific Corporation, Abbott,  Kyoto Medical Planning Co., Ltd., QualiMed, Elixir Medical Corporation, ENDOCOR GmbH, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., Arterial Remodeling Technologies SA.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global biodegradable stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biodegradable stents market

Detailed Segmentation:

• Global Biodegradable Stents Market Segmentation, By Product Type:
  • Coronary Stents
  • Peripheral Stents
• Global Biodegradable Stents Market Segmentation, By Material Type:
  • Polymer-based Stents
  • Metallic Stents
• Global Biodegradable Stents Market Segmentation, By End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
• Global Biodegradable Stents Market Segmentation, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profile:
  • Boston Scientific Corporation
  • Abbott
  • Kyoto Medical Planning Co., Ltd.
  • QualiMed
  • Elixir Medical Corporation
  • ENDOCOR GmbH
  • BIOTRONIK SE & Co. KG
  • Amaranth Medical, Inc.
  • Arterial Remodeling Technologies SA.